Cargando…

Report of the Editor 2022

Detalles Bibliográficos
Autor principal: Schmid, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947874/
https://www.ncbi.nlm.nih.gov/pubmed/36852105
http://dx.doi.org/10.1007/s11408-023-00426-1
_version_ 1784892655089483776
author Schmid, Markus
author_facet Schmid, Markus
author_sort Schmid, Markus
collection PubMed
description
format Online
Article
Text
id pubmed-9947874
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-99478742023-02-23 Report of the Editor 2022 Schmid, Markus Financ Mark Portf Mang Article Springer US 2023-02-23 2023 /pmc/articles/PMC9947874/ /pubmed/36852105 http://dx.doi.org/10.1007/s11408-023-00426-1 Text en © The Author(s) under exclusive licence to Swiss Society for Financial Market Research 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Schmid, Markus
Report of the Editor 2022
title Report of the Editor 2022
title_full Report of the Editor 2022
title_fullStr Report of the Editor 2022
title_full_unstemmed Report of the Editor 2022
title_short Report of the Editor 2022
title_sort report of the editor 2022
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947874/
https://www.ncbi.nlm.nih.gov/pubmed/36852105
http://dx.doi.org/10.1007/s11408-023-00426-1
work_keys_str_mv AT schmidmarkus reportoftheeditor2022